Jove
Visualize
Contact Us

Related Experiment Videos

New developments in approaches to smoking cessation

D E Jorenby1

  • 1Center for Tobacco Research and Intervention, Madison, WI 53706, USA.

Current Opinion in Pulmonary Medicine
|June 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.

Clinical pharmacology and therapeutics·2011
Same author

Smoking cessation strategies for the 21st century.

Circulation·2001
Same author

Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?

Journal of consulting and clinical psychology·2001
Same author

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Clinical therapeutics·2001
Same author

Are higher doses of nicotine replacement more effective for smoking cessation?

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2000
Same author

Response to nicotine dependence treatment in smokers with current and past alcohol problems.

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine·2000
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

New treatments for tobacco addiction, including nicotine nasal spray and inhalers, effectively reduce cravings and improve cessation rates. Over-the-counter nicotine patches and gum offer wider access, with safety confirmed in high-risk groups.

Area of Science:

  • Public Health
  • Addiction Medicine
  • Pharmacology

Background:

  • Tobacco use remains a primary cause of preventable morbidity and mortality in the U.S.
  • Significant healthcare expenditures are linked to tobacco-related illnesses.
  • The development of novel cessation aids is crucial for public health initiatives.

Purpose of the Study:

  • To review recent advancements in treatments for tobacco addiction.
  • To evaluate the efficacy and safety of new and existing nicotine replacement therapies (NRTs).
  • To assess the impact of over-the-counter availability of NRTs.

Main Methods:

  • Review of newly introduced nicotine delivery systems (nasal spray, inhaler).
  • Analysis of data on the efficacy of NRTs in reducing craving and withdrawal symptoms.

Related Experiment Videos

  • Examination of safety data for NRTs in specific populations, including adolescents, pregnant women, and individuals with cardiovascular disease.
  • Assessment of the implications of making nicotine patches and gum available without a prescription.
  • Main Results:

    • New nicotine nasal spray and inhaler demonstrated significant reductions in craving and withdrawal compared to placebo.
    • These new delivery systems improved medium- to long-term smoking cessation rates.
    • Nicotine patches and gum are now available over-the-counter in the U.S., potentially increasing accessibility.
    • Safety data indicate that NRTs pose minimal additional risk for adolescents, pregnant women, and patients with cardiovascular disease.

    Conclusions:

    • Novel nicotine delivery systems offer effective options for tobacco cessation.
    • Increased accessibility of NRTs through over-the-counter availability may enhance public health efforts.
    • Current evidence supports the safety of NRTs even in vulnerable populations, encouraging wider therapeutic use.